Back to
Exchange Traded Concepts, LLC
JANX
Showing 4 of 9 quarters
Position history for
Exchange Traded Concepts, LLC's holdings in Janux Therapeutics, Inc.
No. Exchange Traded Concepts exited its JANX (Janux Therapeutics) position in Q2 2025. Its Q1 2025 13F listed 4,043 shares worth $109,161. Exchange Traded Concepts first reported JANX in Q2 2023 and held it in 8 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$152,509
Total Shares Change
-3,357
Quarter-by-Quarter History